Trademark: 79370605
Status Date
Tuesday, March 12, 2024
Filing Date
Thursday, March 2, 2023
Published for Opposition
Tuesday, April 16, 2024
5 Medicines for the treatment and control of inflammation and immune system related diseases; pharmaceutical preparations for inflammation and immune system related diseases; chemical preparations for pharmaceutical or medical purposes, namely, for inflammation and immune system related diseases; biological preparations for the treatment and control of inflammation and immune system related diseases; allergy relief medication; allergy medication
42 Biotechnology research; biomedical research services; pharmaceutical research services; scientific research and development; research and development of new products for others; scientific laboratory services; quality control for others; quality evaluation services for the medical and anesthesia industries; scientific research and development in the field of immunity and antibody screening; research and development services in the field of antibodies
Mar 27, 2024
Notification Of Possible Opposition Sent To Ib
Mar 27, 2024
Notice Of Publication
Mar 27, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 11, 2024
Approved For Pub - Principal Register
Feb 14, 2024
Refusal Processed By Ib
Jan 19, 2024
Non-Final Action Mailed - Refusal Sent To Ib
Jan 19, 2024
Refusal Processed By Mpu
Dec 2, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Dec 1, 2023
Non-Final Action Written
Dec 1, 2023
Assigned To Examiner
Jun 6, 2023
Application Filing Receipt Mailed
Jun 1, 2023
New Application Office Supplied Data Entered
Jun 1, 2023
Limitation From Original Application Entered
May 25, 2023
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
